BIOSYNCHRONOUS TRANSDERMAL DRUG DELIVERY
First Claim
1. A method for delivering a bioactive agent to a human or animal comprising:
- providing a trans dermal drug delivery device coupled to the human or animal, the delivery device having a source of the bioactive agent, a programmable timing mechanism, and a mechanism for causing the bioactive agent to be delivered transdermally in response to the timing mechanism; and
timing routines implemented by the timing mechanism, wherein the timing routines are selected to deliver the bioactive agent at a time, rate, sequence and/or cycle that is synchronized with a biological rhythm of the human or animal.
3 Assignments
0 Petitions
Accused Products
Abstract
Systems and methods for treating diseases, addictions and disorders in humans and animals involving synchronizing and tailoring the administration of drug compounds with the body'"'"'s natural circadian rhythms, in order to counteract symptoms when they are likely to be at their worst. Automated and pre programmable transdermal drug administration system are used. This system can also utilize a pump or pressurized reservoir, and/or a system for removing depleted carrier solution, or other modulated dispensing actuator, in conjunction with micro-fabricated structures commonly referred to as Micro-needles, or heat, or iontophoresis, sonophoresis, or a wide range of chemical permeation enhancers.
50 Citations
16 Claims
-
1. A method for delivering a bioactive agent to a human or animal comprising:
- providing a trans dermal drug delivery device coupled to the human or animal, the delivery device having a source of the bioactive agent, a programmable timing mechanism, and a mechanism for causing the bioactive agent to be delivered transdermally in response to the timing mechanism; and
timing routines implemented by the timing mechanism, wherein the timing routines are selected to deliver the bioactive agent at a time, rate, sequence and/or cycle that is synchronized with a biological rhythm of the human or animal. - View Dependent Claims (2, 3, 4, 5, 6, 7)
- providing a trans dermal drug delivery device coupled to the human or animal, the delivery device having a source of the bioactive agent, a programmable timing mechanism, and a mechanism for causing the bioactive agent to be delivered transdermally in response to the timing mechanism; and
-
8. A method for treating a symptom, condition, and/or disease comprising:
-
identifying a drug suitable for treating a particular symptom, condition and/or disease;
identifying a biologically superior time for modulating the administration of the a drug;
programming a time-programmable transdermal drug delivery system with a schedule selected to synchronize with the identified biologically superior time for modulating; and
causing the time-programmable transdermal drug delivery system to deliver the active ingredient according to the programmed schedule.
-
-
9. A programmable transdermal drug delivery device comprising:
-
an interface for coupling to the skin of a host;
a reservoir storing a quantity of an active composition;
a delivery mechanism for modulating the quantity of the active composition supplied from the reservoir to the interface in response to a control signal; and
a timing mechanism coupled to the delivery mechanism and configured to generate the control signal according to a programmed administration schedule. - View Dependent Claims (10, 11, 12)
-
-
13. A method for delivering a drug to a human or animal comprising:
-
providing a transdermal drug delivery device coupled to the human or animal, the delivery device having a source of the drug, a programmable timing mechanism, and a mechanism for causing the drug to be delivered transdermally in response to the timing mechanism; and
timing routines implemented by the timing mechanism, wherein the timing routines are selected to deliver the drug at a time when the human or animal is expected to be asleep. - View Dependent Claims (14, 15, 16)
-
Specification